Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Common Equity (2018 - 2025)

Inventiva (IVEVF) posted Common Equity of -$33.2 billion for Q4 2025, down 329122.32% on a QoQ basis from -$10.1 million in Q2 2025, and down 29033.14% year-over-year from N/an in Q4 2024.

Analysis

Inventiva (IVEVF) Common Equity (2018 - 2025) Analysis & Trends

Inventiva has reported Common Equity for 8 years, with the latest figure at -$33.2 billion in Q4 2025.

  • On a quarterly basis, Common Equity fell 29033.14% year-over-year to -$33.2 billion in Q4 2025; TTM through Dec 2025 was -$33.2 billion, a 29033.14% decrease from a year earlier, with the FY2025 full-year figure at -$33.2 billion, down 29033.14% from the prior year.
  • Common Equity was -$33.2 billion for Q4 2025 at Inventiva, down from -$10.1 million in the prior quarter.
  • The five-year high for Common Equity was $123.3 million in Q1 2021, with the low at -$33.2 billion in Q4 2025.
  • Average Common Equity over 5 years is -$3.0 billion, with a median of -$8.3 million recorded in 2023.
  • The sharpest annual moves came in 2021 and 2025: Common Equity jumped 131.92% in 2021, then plunged 29033.14% in 2025.
  • Over 5 years, Common Equity stood at $101.7 million in 2021, then plunged by 54.36% to $46.4 million in 2022, then sank by 174.28% to -$34.5 million in 2023, then tumbled by 230.67% to -$114.0 million in 2024, then slumped by 29033.14% to -$33.2 billion in 2025.
  • The last three Common Equity figures came in at -$33.2 billion (Q4 2025), -$10.1 million (Q2 2025), and -$114.0 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 646.71 Bn 625.95 Bn 17.26 Bn 84.97 Bn
2 AbbVie 442.22 Bn 435.65 Bn 12.70 Bn -5.94 Bn
3 Merck 366.92 Bn 359.78 Bn 12.21 Bn 106.07 Bn
4 Novartis Ag 266.90 Bn 259.21 Bn 11.24 Bn 41.95 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn 85.49 Bn
6 Sanofi 52.44 Bn 45.06 Bn 10.79 Bn 80.86 Bn
7 Revolution Medicines 44.11 Bn 44.11 Bn - 2.61 Bn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn 6.34 Bn
9 United Therapeutics 21.50 Bn 18.84 Bn 683.80 Mn 6.40 Bn
10 Inventiva 693.72 Mn 693.72 Mn - -33.20 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -33.20 Bn
Jun 30, 2025 -10.08 Mn
Dec 31, 2024 -113.96 Mn
Jun 30, 2024 -85.14 Mn
Dec 31, 2023 -34.46 Mn
Jun 30, 2023 -8.35 Mn
Dec 31, 2022 46.40 Mn
Jun 30, 2022 74.40 Mn
Dec 31, 2021 101.66 Mn
Jun 30, 2021 106.60 Mn
Mar 31, 2021 123.34 Mn
Dec 31, 2020 132.60 Mn
Jun 30, 2020 45.97 Mn
Dec 31, 2019 45.82 Mn
Dec 31, 2018 70.31 Mn